B
NVO

Baird’s Novo Nordisk NVO Stock Holding History

Baird’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$10.9M Sell
408,928
-195,148
-32% -$4.49M 0.11% 201
2014
Q4 		$12.8M Buy
604,076
+594,726
+6,361% +$13.3M 0.14% 186
2014
Q3 		$223K Sell
9,350
-458
-5% -$10.5K ﹤0.01% 1032
2014
Q2 		$227K Buy
9,808
+1,020
+12% +$22.5K ﹤0.01% 1058
2014
Q1 		$201K Sell
8,788
-57,492
-87% -$1.22M ﹤0.01% 1074
2013
Q4 		$1.23M Sell
66,280
-2,070
-3% -$36.1K 0.02% 560
2013
Q3 		$1.16M Buy
68,350
+46,670
+215% +$785K 0.02% 551
2013
Q2 		$336K Buy
+21,680
New +$361K 0.01% 885

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Baird's NVO Position: Q1 2015 in Review

Baird reduced its Novo Nordisk (NVO) stake by 32% in Q1 2015, selling an estimated $4.49M and leaving 408,928 shares worth $10.9M. The position accounts for 0.11% of the portfolio, ranked #201.

Baird first reported a position in NVO in Q2 2013 and has held it in 8 quarters since. The position peaked at $12.8M in Q4 2014. 505 funds tracked by Wall St. Rank hold NVO as of Q1 2015.

  • Baird held 408,928 shares of Novo Nordisk worth $10.9M as of Q1 2015.
  • Baird sold 195,148 Novo Nordisk shares in Q1 2015, an estimated $4.49M.
  • Novo Nordisk made up 0.11% of Baird's portfolio in Q1 2015, its #201 holding.
  • Baird first reported a position in Novo Nordisk in Q2 2013 and has held it in 8 quarters since.
  • Baird's Novo Nordisk position peaked at $12.8M in Q4 2014.
  • 505 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.